Aureus Pharma Licenses AurSCOPE® GPCR to Serono
News Apr 12, 2006
Aureus Pharma has announced that Serono has become a customer of its AurSCOPE GPCR knowledge database.
In this multi-year agreement, scientists at Serono Pharmaceutical Research Institute in Geneva will have access to both the AurSCOPE knowledge database and AurQUEST, a web application designed to query Aureus’ knowledge bases.
AurSCOPE GPCR is comprised of detailed biological activity quantitative data from patents and journals form.
G-Protein Coupled Receptors are a major interest for the pharmaceutical industry as they are targets in a number of therapeutic areas including CNS, cardiovascular, metabolic disease, obesity, oncology and others.
"Aureus Pharma’s knowledgebase on GPCR will provide Serono researcher’s with high quality quantitative data which will complement our in-house experimental platform," commented Serono’s Dr. Serge Halazy, Head of Research, Switzerland.
"We are very pleased to have Serono join our growing list of customers in the pharmaceutical and biotechnology industry," said Dr. Andre Michel, CEO of Aureus Pharma.
"Having access to the high quality data in AurSCOPE GCPR will aid researchers in the discovery of new GPCR targeted drugs."
Researchers at the Crick and Imperial College London have generated malaria parasites resistant to a promising new class of candidate antimalarial drugs. By analyzing the structural changes behind the resistance, they identified novel compounds that were immune to this mechanism of resistance.READ MORE